News
Motif Ingredients, a food ingredients company, has launched with $90M in Series A financing to provide next-generation alternative proteins and other ingredients to global food companies.

Motif Ingredients, a food ingredients company, has launched with $90M in Series A financing to provide next-generation alternative proteins and other ingredients to global food companies. Powered by Ginkgo Bioworks' platform for biological engineering, Motif Ingredients says it will leverage biotechnology to create novel solutions for foods that provide consumers with greater choices, without compromising taste or nutrition. Motif investors include Breakthrough Energy Ventures, Louis Dreyfus Company, Fonterra, and Viking Global Investors. Jonathan McIntyre, formerly Head of R&D at Indigo Agriculture and former SVP of R&D at PepsiCo, will lead Motif as CEO. Motif will be headquartered at Ginkgo's Boston Seaport facility.
Consumer demand for alternative foods such as meat substitutes and plant-based beverages grew 17% last year, the company notes, with food companies rapidly innovating to keep up with demand, but obstacles remain to create products that maintain the taste, health profile and integrity of their animal-based counterparts. Motif's ingredients offer a solution to this problem, bringing the nutrition and taste that consumers demand at an accessible price that mass scale food markets require. Using biotechnology and fermentation – rather than animal agriculture – Motif will engineer dozens of proteins derived from dairy, egg and meat without compromising the functionality, taste and nutrition of animal-based ingredients."Sustainability and accessible nutrition are among the biggest challenges facing the food industry today. Consumers are demanding mindful food options, but there's a reigning myth that healthy and plant-based foods must come at a higher price, or cannot taste or function like the animal-based foods they aim to replicate," said Jonathan McIntyre, PhD, CEO of Motif. "Biotechnology and fermentation is our answer, and Motif will be key to propelling the next food revolution with affordable, sustainable and accessible ingredients that meet the standards of chefs, food developers, and visionary brands."Biotechnology is indispensable for catalyzing the next generation of foods. Vital food ingredients, including vitamins, amino acids, enzymes, and flavors, are made through fermentation with genetically engineered yeasts and bacteria in a process similar to brewing beer. Identifying and developing new fermented ingredients – particularly new proteins – that are historically derived from animals requires deep technical resources and experience. With Ginkgo, Motif will accelerate the R&D process for manufacturing new ingredients at a price, taste, and quality in line with what is already available at an everyday food market. Crucially, food companies will be able to outsource this costly and time-intensive R&D process to Motif as a trusted and innovative supplier, while dedicating more time and resources to bringing delicious products and new brands to consumers."To help feed the world and meet consumers' evolving food preferences, traditional and complementary nutritional sources need to co-exist. As a global dairy nutrition company, we see plant- and fermentation-produced nutrition as complementary to animal protein, and in particular cows' milk," says Judith Swales, Fonterra's Chief Operating Officer, Global Consumer and Foodservice Business. "Our partnership with Motif enables us to be part of this emerging area and help meet the nutritional needs of the world's growing population.""Innovative or disruptive solutions are key to responding to changing consumer demand and to addressing the challenge of feeding a growing world population sustainably," said Kristen Eshak Weldon, Head of Food Innovation & Downstream Strategy at Louis Dreyfus Company (LDC), a leading merchant and processor of agricultural goods. "In this sense, we are excited to partner with Motif, convinced that its next-generation ingredients will play a vital role."Motif is the second startup to launch from Ginkgo's platform for biological engineering. The first, Joyn Bio, was launched in September 2017 in a joint venture by Ginkgo and Leaps by Bayer to focus on achieving more sustainable agricultural practices, starting with nitrogen fixation. With Ginkgo's automated foundries and codebase, startups like Motif and Joyn can easily access the vast diversity of biology to grow innovative and sustainable new products. To learn more about Motif, visit motifingredients.com.Set Ingredients Network as a 'Preferred Source' to get quicker access to the news you value.
1 Oct 2026
PerfectaGEL® can cut vegan gummy drying from 36-72 hours to as little as three, depending on the application. Here is the technology behind it.
Read more
30 Sep 2026
Zero-sugar, functional, and indulgent sodas are redefining what a carbonated soft drink can offer in today’s evolving market.
Read more
29 Sep 2026
Premium ready meal innovation – with high-end meals retailing for £10 (around €12) – is heating up in the UK. What are the stand-out attributes for a winning product?
Read more
28 Sep 2026
Startup accelerator programme Breakout Wellness UK is partnering with retail major Holland & Barrett to propel eleven extraordinary startups into growth.
Read more
24 Sep 2026
The functional ingredient creatine is gaining traction in the food and drink industry, as brands ramp up production investment and explore new applications.
Read more
22 Sep 2026
Public health campaigners are celebrating the US government’s move to close the Generally Recognised as Safe (GRAS) loophole, but companies worry it will stifle innovation.
Read more
21 Sep 2026
The Food and Agriculture Organization (FAO) is promoting industrial aquaculture but campaigners say it creates toxic pollution and threatens food sovereignty.
Read more
17 Sep 2026
Nutraceuticals continue to gain ground across the Middle East and Africa with vitamins, probiotics, and functional drinks doing particularly well, says Euromonitor.
Read more
14 Sep 2026
Nestlé is to sell its mainstream vitamin, mineral, and supplement (VMS) business for $1 billion – a logical move away from “the unprofitable middle” of this category, say experts.
Read more
10 Sep 2026
Will the US dietary guidelines change the way Americans eat, swapping ultra-processed foods for whole foods? We asked Dr Barry Popkin, renowned nutrition and obesity researcher.
Read more